These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9735147)

  • 1. Total synthesis of 17,17,18,18-d4-iPF2alpha-VI and quantification of iPF2alpha-VI in human urine by gas chromatography/mass spectrometry.
    Adiyaman M; Lawson JA; Khanapure SP; FitzGerald GA; Rokach J
    Anal Biochem; 1998 Aug; 262(1):45-56. PubMed ID: 9735147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.
    Lawson JA; Li H; Rokach J; Adiyaman M; Hwang SW; Khanapure SP; FitzGerald GA
    J Biol Chem; 1998 Nov; 273(45):29295-301. PubMed ID: 9792628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS methods for the detection of isoprostanes (iPF2alpha-III and 8,12-iso-iPF2alpha-VI) as biomarkers of CCl4-induced oxidative damage to hepatic tissue.
    Sicilia T; Mally A; Schauer U; Pähler A; Völkel W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):48-55. PubMed ID: 18160027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IPF2alpha-I: an index of lipid peroxidation in humans.
    Praticò D; Barry OP; Lawson JA; Adiyaman M; Hwang SW; Khanapure SP; Iuliano L; Rokach J; FitzGerald GA
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3449-54. PubMed ID: 9520386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of isoprostanes: discovery and quantitation in biological systems.
    Rokach J; Kim S; Bellone S; Lawson JA; Praticò D; Powell WS; FitzGerald GA
    Chem Phys Lipids; 2004 Mar; 128(1-2):35-56. PubMed ID: 15037151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning.
    Kadiiska MB; Gladen BC; Baird DD; Graham LB; Parker CE; Ames BN; Basu S; Fitzgerald GA; Lawson JA; Marnett LJ; Morrow JD; Murray DM; Plastaras J; Roberts LJ; Rokach J; Shigenaga MK; Sun J; Walter PB; Tomer KB; Barrett JC; Mason RP
    Free Radic Biol Med; 2005 Mar; 38(6):711-8. PubMed ID: 15721981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
    Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
    Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix effect in F₂-isoprostanes quantification by HPLC-MS/MS: a validated method for analysis of iPF₂α-III and iPF₂α-VI in human urine.
    Petrosino T; Serafini M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 965():100-6. PubMed ID: 24999618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoprostanes--new possibility of the oxidative stress estimation].
    Dołegowska B; Chlubek D
    Przegl Lek; 2004; 61(12):1410-4. PubMed ID: 15850339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down's syndrome is associated with increased 8,12-iso-iPF2alpha-VI levels: evidence for enhanced lipid peroxidation in vivo.
    Praticò D; Iuliano L; Amerio G; Tang LX; Rokach J; Sabatino G; Violi F
    Ann Neurol; 2000 Nov; 48(5):795-8. PubMed ID: 11079545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.
    Praticò D; Clark CM; Lee VM; Trojanowski JQ; Rokach J; FitzGerald GA
    Ann Neurol; 2000 Nov; 48(5):809-12. PubMed ID: 11079549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
    Praticò D; Basili S; Vieri M; Cordova C; Violi F; Fitzgerald GA
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1709-14. PubMed ID: 9847257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary 8-epi-PGF2alpha and its endogenous beta-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress.
    Nourooz-Zadeh J; Cooper MB; Ziegler D; Betteridge DJ
    Biochem Biophys Res Commun; 2005 May; 330(3):731-6. PubMed ID: 15809058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 2: Quantification methods].
    Berdeaux O; Scruel O; Durand T; Cracowski JL
    Pathol Biol (Paris); 2005 Jul; 53(6):356-63. PubMed ID: 16004948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation.
    Tacconelli S; Capone ML; Patrignani P
    Methods Mol Biol; 2010; 644():165-78. PubMed ID: 20645173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of urinary 8-iso-PGF2alpha using liquid chromatography-tandem mass spectrometry and association with elevated troponin levels.
    Saenger AK; Laha TJ; Edenfield MJ; Sadrzadeh SM
    Clin Biochem; 2007 Nov; 40(16-17):1297-304. PubMed ID: 17854792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased formation of distinct F2 isoprostanes in hypercholesterolemia.
    Reilly MP; Praticò D; Delanty N; DiMinno G; Tremoli E; Rader D; Kapoor S; Rokach J; Lawson J; FitzGerald GA
    Circulation; 1998 Dec 22-29; 98(25):2822-8. PubMed ID: 9860782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders.
    Cracowski JL; Marpeau C; Carpentier PH; Imbert B; Hunt M; Stanke-Labesque F; Bessard G
    Arthritis Rheum; 2001 May; 44(5):1143-8. PubMed ID: 11352247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of urinary F(2)-isoprostanes as markers of in vivo lipid peroxidation-A comparison of enzyme immunoassay with gas chromatography/mass spectrometry.
    Proudfoot J; Barden A; Mori TA; Burke V; Croft KD; Beilin LJ; Puddey IB
    Anal Biochem; 1999 Aug; 272(2):209-15. PubMed ID: 10415090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.